ロード中...
Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes
Insulin degludec (IDeg) is a new basal insulin with an ultra-long and stable glucose-lowering effect. We compared once-daily IDeg and insulin glargine (IGlar), both in combination with metformin ± dipeptidyl peptidase-4 inhibitors, in a 52-week, open-label, treat-to-target trial in patients with typ...
保存先:
| 出版年: | Diabetes Obes Metab |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4237540/ https://ncbi.nlm.nih.gov/pubmed/24495158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12271 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|